Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Medtronic
Harvard Business School
Mallinckrodt
McKesson

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for NORDSTRUM v. MYLAN, INC. (D.N.J. 2017)

See Plans and Pricing

« Back to Dashboard

NORDSTRUM v. MYLAN, INC. (D.N.J. 2017)

Docket   Start Trial Date Filed 2017-04-07
Court District Court, D. New Jersey Date Terminated 2017-08-08
Cause 15:1 Antitrust Litigation Assigned To Madeline Cox Arleo
Jury Demand Plaintiff Referred To Leda D. Wettre
Parties ANGIE NORDSTRUM; CARLY BOWERSOCK; KING PHARMACEUTICALS LLC; MERIDIAN MEDICAL TECHNOLOGIES, INC.; MYLAN SPECIALTY L.P.; MYLAN, INC.; PFIZER, INC.
Patents 7,449,012; 7,794,432; 8,048,035; 8,870,827
Attorneys ARNOLD B. CALMANN; DAVID E. DELORENZI; DONALD A. ECKLUND; JAMES E. CECCHI; JEFFREY S. SOOS; SILVIA M. MEDINA
Firms Carella, Byrne, Cecchi, Olstein, Brody & Agnello, P.C.; Fenwick & West
Link to Docket External link to docket
Small Molecule Drugs cited in NORDSTRUM v. MYLAN, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for NORDSTRUM v. MYLAN, INC. (D.N.J. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 holder of Patent No. 7,449,012 B2 (the “‘012 Patent”) and Patent No. 7,794,432 B2 (the “‘432 Patent”) covering…2011, and 2014, Meridian obtained Patent Numbers D543273S1, US 7,449,012 B2, US 7,794,432 B2, US 8,048,035… (D. Del.), alleged infringement of U.S. Patent No. 7,449,012, which is not set to expire until 2025.… “evergreening” the EpiPen device patents (a tactic by which patent holders make minor or insignificant…Meridian obtained the ‘012 Patent on November 11, 2008 and the ‘432 Patent on September 14, 2010. Meridian External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Merck
Boehringer Ingelheim
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.